Sacituzumab govitecan

Trodelvy 200 MG Polvo Para Concentrado Para Solucion Para Perfusion

200 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 26 Nov 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TrodelvyEuropean UnionAuthorised

TrodelvyBrazil · Gilead Sciences Farmaceutica do Brasil LtdaSame brand
TrodelvyCanada · 180 MG / VIAL · Powder For Solution · Gilead Sciences Canada INCSame brand
TrodelvyEuropean Union · Gilead Sciences Ireland UCSame brand
TrodelvyCroatiaSame brand
TrodelvyItaly · Polvere per concentrato per soluzione per infusione · Gilead Sciences Ireland UcSame brand
Trodelvy 200 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Gilead Sciences Ireland UC

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sacituzumab govitecan

Trodelvy 200 MG Polvo Para Concentrado Para Solucion Para Perfusion

200 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 26 Nov 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TrodelvyEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

TrodelvySaudi Arabia · BSP Pharmaceuticals

Trodelvy Powder for Solution for Infusion 180 MG/VialSingapore · 180 mg / vial · injection, powder, lyophilized, for solution · Gilead Sciences Singapore Pte. LTD.

TrodelvyUnited States · 180MG · injectable · Immunomedics INC

Packs

Pack	Code	Status
TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial	732220

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Sacituzumab govitecan
Strength: 200 mg
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 26 Nov 2021
Registration: 1211592001
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/21/1592